Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Addex Pharmaceuticals, a Switzerland-based discoverer and developer of small molecule drugs, called allosteric modulators, has named Bharatt Chowrira as the new CEO.
Subscribe to our email newsletter
Prior to Addex, Chowrira worked as the senior vice president & chief operating officer of Nektar Therapeutics till January 2011.
Before Nektar, Chowrira worked as the executive director of Worldwide Licensing & External Research at Merck and was responsible for identifying and evaluating product and technology partnering opportunities across all therapeutics areas in Asia.
Chowrira said he looks forward to building on the success achieved to date and expanding Addex’s relationships within the global pharmaceutical and biotechnology industry.